These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 688175)

  • 21. [The current state of CNS prophylaxis with 198 gold colloid and 60 telecobalt in juvenile acute leukemias and non-Hodgkin's lymphomas].
    Metz O; Blau HJ; Weinmann G; Zastrow J
    Dtsch Gesundheitsw; 1976 Dec; 31(52):2472-6. PubMed ID: 1036987
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytotoxic T lymphocytes for leukemia and lymphoma.
    Bollard CM; Barrett AJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):565-9. PubMed ID: 25696912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the management of lymphomas and leukemias.
    DIAMOND HD
    Med Clin North Am; 1953 May; 1():843-67. PubMed ID: 13086014
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent advances in treatment of leukemias and lymphomas.
    IRWIN GE
    W V Med J; 1952 Sep; 48(9):262-4. PubMed ID: 13006097
    [No Abstract]   [Full Text] [Related]  

  • 25. [Incidence of acute leukemias, lymphomas and thyroid cancers in children under 15 years, living around the Marcoule nuclear site from 1985 to 1995].
    Bouges S; Daurès JP; Hébrard M
    Rev Epidemiol Sante Publique; 1999 Jun; 47(3):205-17. PubMed ID: 10422115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
    Kubuschok B; Trepel M
    Expert Opin Drug Discov; 2017 Jul; 12(7):733-745. PubMed ID: 28494631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current concepts of leukemia and lymphoma: etiology, pathogenesis, and therapy.
    Ann Intern Med; 1976 Sep; 85(3):351-66. PubMed ID: 786094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulation against leukemias and lymphomas: a realistic future treatment?
    Mittal S; Marshall NA; Barker RN; Vickers MA
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):101-8. PubMed ID: 17719232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukemia: A model for drug development.
    Keating MJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2598-604. PubMed ID: 9815664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2010 Dec; 57(4):253-347. PubMed ID: 21183421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intensive treatment and autologous bone marrow transplantation in cases of leukemias and lymphomas in relapse].
    Chapuis B; Helg C; Maurice P; Aapro M; Pipard G
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1522-3. PubMed ID: 3909388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teniposide in lymphomas and leukemias.
    Sonneveld P
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):59-64. PubMed ID: 1411640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.
    Angata T; Nycholat CM; Macauley MS
    Trends Pharmacol Sci; 2015 Oct; 36(10):645-660. PubMed ID: 26435210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting.
    Wayne AS; Shin-Kashiyama E; Sposto R; Gaynon P
    Pediatr Hematol Oncol; 2017; 34(6-7):349-354. PubMed ID: 29120691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support.
    Johnsen HE; Björkstrand B; Carlson K; Gruber A; Blystad A; Fast A; Boesen AM; Björkholm M; Sallerfors B; Ruutu T; Carneskog J; Malm A; Geisler C; Lehtinen M; Schrøder H; Brinch L; Remes K; Tidefelt U; Heilmann C; Hörnsten P; Thorling K; Daugaard G
    Leuk Lymphoma; 1996 Dec; 24(1-2):81-91. PubMed ID: 9049964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of acute leukemias].
    Stefanović S; Ristić M; Banićević B
    Bilt Hematol Transfuz; 1976; 4(1-2):9-17. PubMed ID: 1066130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
    Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
    Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of elderly patients with leukemias and malignant lymphomas].
    Wedding U; Höffken K
    Wien Med Wochenschr; 2002; 152(7-8):177-81. PubMed ID: 12017743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunology Letters. IMmune-related Pathologies: Understanding Leukocyte Signaling and Emerging Therapies--IMPULSE 2013. Introduction.
    Erdei A; Sármay G; Matkó J; Prechl J
    Immunol Lett; 2014 Aug; 160(2):107-8. PubMed ID: 24721899
    [No Abstract]   [Full Text] [Related]  

  • 40. Leukemia and lymphoma. New directions.
    Semin Hematol; 1978 Oct; 15(4):321-457. PubMed ID: 734444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.